Mark Abel
5Patents
3h-index
24Co-inventors
53Inventor score
Filing activity: Jan 16, 1998 → Oct 30, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7160867B2 | Rapamycin carbohydrate derivatives | Chemistry; Metallurgy | 34 | Expired |
| US7141648B2 | Synthesis of cyclosporin analogs | Emerging Cross-Sectional Technologies | 7 | Expired |
| US9200038B2 | Cyclosporine analogue molecules modified at amino acid 1 and 3 | Emerging Cross-Sectional Technologies | 5 | Active |
| US9714271B2 | Cyclosporine analogue molecules modified at amino acid 1 and 3 | Emerging Cross-Sectional Technologies | 0 | Active |
| US6153616A | Triazoles as therapeutic agents for fungal infections | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.